Cargando…
Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy
To assess the therapeutic potential and the safety of intravitreous use of a bone marrow mononuclear fraction (BMMF) containing CD34+ cells in patients with Stargardt type macular dystrophy. The study was conducted on 10 patients with Stargardt dystrophy with worse eye visual acuity ≤ 20/125. A bone...
Autores principales: | Cotrim, Carina Costa, Vieira Messias, André M., Jorge, Rodrigo, Siqueira, Rubens Camargo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787861/ https://www.ncbi.nlm.nih.gov/pubmed/33488737 http://dx.doi.org/10.1155/2020/8828256 |
Ejemplares similares
-
Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular degeneration
por: Cotrim, Carina Costa, et al.
Publicado: (2017) -
Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular Dystrophy
por: Strauss, Rupert W., et al.
Publicado: (2016) -
Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
por: Piccardi, Marco, et al.
Publicado: (2019) -
A Splicing Variant in RDH8 Is Associated with Autosomal Recessive Stargardt Macular Dystrophy
por: Zampatti, Stefania, et al.
Publicado: (2023) -
MACULAR ATROPHY AND PHENOTYPIC VARIABILITY IN AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY DUE TO PROM1 MUTATION
por: Ricca, Aaron M., et al.
Publicado: (2023)